WO2004078020A3 - Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia - Google Patents

Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia Download PDF

Info

Publication number
WO2004078020A3
WO2004078020A3 PCT/EP2004/004008 EP2004004008W WO2004078020A3 WO 2004078020 A3 WO2004078020 A3 WO 2004078020A3 EP 2004004008 W EP2004004008 W EP 2004004008W WO 2004078020 A3 WO2004078020 A3 WO 2004078020A3
Authority
WO
WIPO (PCT)
Prior art keywords
polymerase chain
reverse transcriptase
chain reaction
time quantitative
standardized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2004/004008
Other languages
French (fr)
Other versions
WO2004078020A2 (en
Inventor
Jean Gabert
Emmanuel Beillard
Wanli Bi
Dongen Jacques Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aix Marseille Universite
Original Assignee
Universite de la Mediterranee Aix Marseille II
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de la Mediterranee Aix Marseille II filed Critical Universite de la Mediterranee Aix Marseille II
Priority to AT04718310T priority Critical patent/ATE518004T1/en
Priority to EP04718310A priority patent/EP1601796B1/en
Priority to JP2006505146A priority patent/JP4706863B2/en
Priority to US10/548,188 priority patent/US20060240434A1/en
Publication of WO2004078020A2 publication Critical patent/WO2004078020A2/en
Publication of WO2004078020A3 publication Critical patent/WO2004078020A3/en
Anticipated expiration legal-status Critical
Priority to US13/022,004 priority patent/US20110223595A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention relates to in a real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) method for minimal residual disease detection in leukemic patients through amplification of a fusion gene transcript, comprising: (i) selecting amplifiable and qualified patient samples for subsequent analysis; (ii) defining optimal conditions for performing the RT reaction; (iii) defining optimal conditions for RQ-PCR protocol; and (iv) establishing a standardized procedure for data analysis.
PCT/EP2004/004008 2003-03-07 2004-03-08 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia Ceased WO2004078020A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AT04718310T ATE518004T1 (en) 2003-03-07 2004-03-08 STANDARDIZED AND OPTIMIZED QUANTITATIVE REVERSE TRANSCRIPTASE REAL-TIME POLYMERASE CHAIN REACTION METHOD FOR DETECTING MINIMAL RESIDUAL DISEASE IN LEUKEMIA
EP04718310A EP1601796B1 (en) 2003-03-07 2004-03-08 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia
JP2006505146A JP4706863B2 (en) 2003-03-07 2004-03-08 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detecting MRD in leukemia
US10/548,188 US20060240434A1 (en) 2003-03-07 2004-03-08 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia
US13/022,004 US20110223595A1 (en) 2003-03-07 2011-02-07 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03290572A EP1454994A1 (en) 2003-03-07 2003-03-07 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of MRD in leukemia
EP03290572.1 2003-03-07

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/022,004 Continuation US20110223595A1 (en) 2003-03-07 2011-02-07 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia

Publications (2)

Publication Number Publication Date
WO2004078020A2 WO2004078020A2 (en) 2004-09-16
WO2004078020A3 true WO2004078020A3 (en) 2005-03-31

Family

ID=32799106

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/004008 Ceased WO2004078020A2 (en) 2003-03-07 2004-03-08 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia

Country Status (7)

Country Link
US (2) US20060240434A1 (en)
EP (5) EP1454994A1 (en)
JP (1) JP4706863B2 (en)
AT (2) ATE518004T1 (en)
DE (1) DE602004023659D1 (en)
ES (2) ES2370339T3 (en)
WO (1) WO2004078020A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206920B2 (en) * 2007-03-26 2012-06-26 Arnold Ganser Diagnostic assay for the specific treatment of acute myeloid leukemia
CN101624621B (en) * 2008-07-11 2012-01-18 北京大学人民医院 Kit for quantitatively detecting BCR/ABL mRNA level
US9777332B2 (en) 2011-03-31 2017-10-03 St. Jude Children's Research Hospital Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
WO2013119950A2 (en) * 2012-02-08 2013-08-15 Insight Genetics, Inc. Methods and compositions relating to fusions of ros1 for diagnosing and treating cancer
MA35216B1 (en) * 2012-09-13 2014-07-03 Mascir Probes and primers for detecting bcr-abl gene in duplex reaction
CN102925556B (en) * 2012-09-29 2014-09-17 童永清 Kit for detecting mRNA expression quantity of m BCR fusion gene
CN102876799B (en) * 2012-10-18 2014-01-01 北京大学人民医院 Multiple real-time quantitative polymerase chain reaction (PCR) kit for detecting mixed lineage leukemia (MLL) relative fuse genes
MA36330B1 (en) * 2013-10-10 2016-04-29 Mascir Morrocan Foundation For Advanced Science Innovation & Res Kit for the diagnosis of chronic myeloide leukemia in multiplex reaction and its applications in the monitoring of treatment and residual disease
EP3201358A1 (en) * 2014-10-02 2017-08-09 Université de Montréal Markers of poor prognosis acute myeloid leukemias (amls) and uses thereof
JP6531312B2 (en) * 2014-10-17 2019-06-19 東洋鋼鈑株式会社 Method for detecting BCR-ABL inhibitor resistance related mutation and data acquisition method for predicting BCR-ABL inhibitor resistance using the same
WO2016183679A1 (en) * 2015-05-21 2016-11-24 Université de Montréal Prognostic markers of acute myeloid leukemia survival
CN106399462A (en) * 2015-07-27 2017-02-15 上海睿玻生物科技有限公司 BCR-ABL fusion gene amplification kit and BCR-ABL fusion gene detection kit
RU2638800C2 (en) * 2015-12-29 2017-12-15 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Method for tumour b lymphoblasts availability markers determination
CN107674914A (en) * 2016-08-02 2018-02-09 熊术道 One step single tube standard measure RT PCR detect the expression quantity of chronic myelogenous leukemia BCR ABL1 genes
CN108823306A (en) * 2017-05-03 2018-11-16 杭州赫玛生物科技有限公司 The system and method for detecting leukaemia cell
CN108676848B (en) * 2018-05-31 2022-04-22 上海科医联创医学检验所有限公司 Mixed gene, standard plasmid and kit for detecting fusion gene and preparation method thereof
CN109554472A (en) * 2018-12-18 2019-04-02 武汉迪安医学检验实验室有限公司 Kit for detecting TEL-AML1 fusion gene
CN111235148A (en) * 2020-03-26 2020-06-05 迈杰转化医学研究(苏州)有限公司 DNA probe pool, lymphoma detection kit containing DNA probe pool, and preparation method and application of lymphoma detection kit
CN111733238B (en) * 2020-05-26 2021-08-03 广州血康陆道培生物技术有限公司 Primer group for identifying 3 splice bodies of PML-RAR alpha fusion gene and kit and application thereof
CN112280866A (en) * 2020-11-24 2021-01-29 福州艾迪康医学检验所有限公司 Method, primer and probe for screening 14 fusion genes related to acute promyelocytic leukemia by fluorescent quantitative PCR technology
CN113637756A (en) * 2021-08-18 2021-11-12 武汉良培医学检验实验室有限公司 A probe set and its kit for simultaneous detection of multiple targets and single holes
CN116970704B (en) * 2023-08-22 2024-05-17 迈杰转化医学研究(苏州)有限公司 Primer probe combination for detecting mutation of BCR-ABL kinase region and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191255B1 (en) * 1995-07-14 2001-02-20 Fuji Yakuhin Kogyo Kabushiki Kaisha Protein and monoclonal antibody specific thereto
AU2001239953A1 (en) * 2000-03-01 2001-09-12 University Of South Florida Methods of modulating cell-adhesion mediated drug resistance
EP1272668B1 (en) * 2000-04-03 2007-02-14 Corixa Corporation Methods, compositions and kits for the detection and monitoring of breast cancer
AU2001278859A1 (en) * 2000-06-29 2002-01-14 University Of Florida Ubiquitin ligase
US7363168B2 (en) * 2001-10-02 2008-04-22 Stratagene California Adaptive baseline algorithm for quantitative PCR
US7198897B2 (en) * 2001-12-19 2007-04-03 Brandeis University Late-PCR
DE10209071A1 (en) * 2002-02-28 2003-09-25 Roboscreen Ges Fuer Molekulare Standardized polynucleotide system, useful for quantitative, real-time determination of nucleic acid, comprises stabilized standards, primers and probe
US20030170724A1 (en) * 2002-03-08 2003-09-11 Anderson David C. Methods of identifying target polypeptides

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
AMABILE MARILINA ET AL: "Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia.", HAEMATOLOGICA, vol. 86, no. 3, March 2001 (2001-03-01), pages 252 - 259, XP002249336, ISSN: 0390-6078 *
BLOOD, vol. 96, no. 11 Part 1, 16 November 2000 (2000-11-16), 42nd Annual Meeting of the American Society of Hematology;San Francisco, California, USA; December 01-05, 2000, pages 313a, ISSN: 0006-4971 *
BOLUFER PASCUAL ET AL: "Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.", HAEMATOLOGICA, vol. 85, no. 12, December 2000 (2000-12-01), pages 1248 - 1254, XP002249337, ISSN: 0390-6078 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 16 November 2000 (2000-11-16), MITTERBAUER ADELHEID ET AL: "Quantification of minimal residual disease in patients with acute promyelocytic leukemia (APL) by real time quantitative RT-PCR with specific fluorescent hybridization probes.", XP002249338, Database accession no. PREV200100312442 *
DONGEN VAN J J M ET AL: "STANDARDIZED RT-PCR ANALYSIS OF FUSION GENE TRANSCRIPTS FROM CHROMOSOME ABERRATIONS IN ACUTE LEUKEMIA FOR DETECTION OF MINIMAL RESIDUAL DISEASE.REPORT OF THE BIOMED-1 CONCERTED ACTION: INVESTIGATION OF MINIMAL RESIDUAL DISEASE IN ACUTE LEUKEMIA", LEUKEMIA, MACMILLAN PRESS LTD, US, vol. 13, no. 12, December 1999 (1999-12-01), pages 1901 - 1928, XP000878700, ISSN: 0887-6924 *
EMIG M ET AL: "Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR", LEUKEMIA, MACMILLAN PRESS LTD, US, vol. 13, no. 11, November 1999 (1999-11-01), pages 1825 - 1832, XP002249335, ISSN: 0887-6924 *
HEID C A ET AL: "REAL TIME QUANTITATIVE PCR", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 6, no. 10, 1 October 1996 (1996-10-01), pages 986 - 994, XP000642795, ISSN: 1088-9051 *
MENSINK E ET AL: "Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR", BRITISH JOURNAL OF HAEMATOLOGY, OXFORD, GB, vol. 102, no. 3, August 1998 (1998-08-01), pages 768 - 774, XP002227390, ISSN: 0007-1048 *

Also Published As

Publication number Publication date
EP1806416B9 (en) 2010-03-10
US20110223595A1 (en) 2011-09-15
EP1806415A3 (en) 2007-07-18
US20060240434A1 (en) 2006-10-26
ES2337301T3 (en) 2010-04-22
DE602004023659D1 (en) 2009-11-26
EP1806416A3 (en) 2007-07-18
EP1806416B1 (en) 2009-10-14
EP1454994A1 (en) 2004-09-08
ATE518004T1 (en) 2011-08-15
EP1601796B1 (en) 2011-07-27
EP1806415A2 (en) 2007-07-11
ES2370339T3 (en) 2011-12-14
JP2006519601A (en) 2006-08-31
JP4706863B2 (en) 2011-06-22
EP2204457A2 (en) 2010-07-07
EP2204457A3 (en) 2011-01-19
EP1806416A2 (en) 2007-07-11
EP1601796A2 (en) 2005-12-07
WO2004078020A2 (en) 2004-09-16
ATE445716T1 (en) 2009-10-15

Similar Documents

Publication Publication Date Title
WO2004078020A3 (en) Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia
Drosten et al. Molecular diagnostics of viral hemorrhagic fevers
EP0878553B1 (en) Strand displacement amplification of RNA targets
EP1322782B1 (en) Method of nucleic acid typing or sequencing
EP2149614A8 (en) Primers for the detection of Mycobacterium tubeculosis
WO1995035390A1 (en) Ligation-dependent amplification for the detection of infectious pathogens and abnormal genes
WO2014015098A1 (en) A method of normalizing biological samples
CN113005200B (en) Primer composition for detecting sarcoma fusion gene mutation, kit and application
WO2007086935A3 (en) Methods of amplifying and sequencing nucleic acids
AU2002324135A1 (en) Methods for detecting dna originating from different individuals in one sample
WO2006026601A3 (en) Homogeneous enzyme immunoassay for oral fluid
CN106591473B (en) A kind of people MTHFR and MTRR genetic polymorphism detections primer, probe, kit and method
DE60016275D1 (en) Helicobacter pylori antigene in blut
WO2003027638A8 (en) Methods for detecting genetic mosaicisms using arrays
JP2016136968A (en) Dengue virus assay
JP2023520936A (en) Hyplex guide pooling for nucleic acid detection
GB0500996D0 (en) Detection method and materials therefor
Dong et al. Cutting-edge RNA quantitative detection methods for rapid and on-site analysis
WO2005056839A3 (en) Primers and probes for detecting genital hpv genotypes
WO2003060520A3 (en) Sample preparation for the detection of infectious agents
CN102485906A (en) Dual amplification method for template linear amplification and multi-biotin signal
WO2001081621A3 (en) Method, diagnostic kit and microarray for determining the rhesus factor
EP1612284A1 (en) Method of detecting and quantifying cytomegalovirus
WO2006018243A1 (en) Method for the analysis of methylated dna
WO2004011612A3 (en) Method of detecting and quantifying hepatitis c virus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006505146

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004718310

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004718310

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006240434

Country of ref document: US

Ref document number: 10548188

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10548188

Country of ref document: US